Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 3958 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 4024 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 7044 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 14403 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 18195 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 20380 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 23978 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 39049 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 41843 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 49635 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 72750 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | 110183 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | Peak area normalized | female | diabetic | Neuropathy | |
Reversed phase NEGATIVE ION MODE | PYRUVIC ACID (M-H)- | Peak area normalized | female | diabetic | no neuropathy |